JP2016504368A5 - - Google Patents

Download PDF

Info

Publication number
JP2016504368A5
JP2016504368A5 JP2015550786A JP2015550786A JP2016504368A5 JP 2016504368 A5 JP2016504368 A5 JP 2016504368A5 JP 2015550786 A JP2015550786 A JP 2015550786A JP 2015550786 A JP2015550786 A JP 2015550786A JP 2016504368 A5 JP2016504368 A5 JP 2016504368A5
Authority
JP
Japan
Prior art keywords
amine
polymer
composition according
polymer matrix
functional drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015550786A
Other languages
English (en)
Japanese (ja)
Other versions
JP6359032B2 (ja
JP2016504368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/077934 external-priority patent/WO2014106016A1/en
Publication of JP2016504368A publication Critical patent/JP2016504368A/ja
Publication of JP2016504368A5 publication Critical patent/JP2016504368A5/ja
Application granted granted Critical
Publication of JP6359032B2 publication Critical patent/JP6359032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015550786A 2012-12-28 2013-12-27 経皮薬物送達用のマルチポリマー組成物 Active JP6359032B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261747117P 2012-12-28 2012-12-28
US61/747,117 2012-12-28
PCT/US2013/077934 WO2014106016A1 (en) 2012-12-28 2013-12-27 Multi-polymer compositions for transdermal drug delivery

Publications (3)

Publication Number Publication Date
JP2016504368A JP2016504368A (ja) 2016-02-12
JP2016504368A5 true JP2016504368A5 (cg-RX-API-DMAC7.html) 2017-02-09
JP6359032B2 JP6359032B2 (ja) 2018-07-18

Family

ID=49956518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015550786A Active JP6359032B2 (ja) 2012-12-28 2013-12-27 経皮薬物送達用のマルチポリマー組成物

Country Status (8)

Country Link
US (2) US9295726B2 (cg-RX-API-DMAC7.html)
EP (1) EP2938335B1 (cg-RX-API-DMAC7.html)
JP (1) JP6359032B2 (cg-RX-API-DMAC7.html)
AU (1) AU2013370297A1 (cg-RX-API-DMAC7.html)
CA (1) CA2896347A1 (cg-RX-API-DMAC7.html)
ES (1) ES2864327T3 (cg-RX-API-DMAC7.html)
MX (1) MX366230B (cg-RX-API-DMAC7.html)
WO (1) WO2014106016A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614716B2 (en) 2010-10-01 2013-12-24 Apple Inc. Recording a command stream with a rich encoding format for capture and playback of graphics content
TW201431554A (zh) 2012-12-28 2014-08-16 Noven Pharma 左炔諾孕酮(levonorgestrel)及乙烯雌二醇之經皮藥物遞送系統
US11337936B2 (en) 2013-03-14 2022-05-24 Noven Pharmaceuticals, Inc. Amphetamine transdermal compositions with acrylic block copolymer
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
CN105607772B (zh) * 2014-11-13 2020-11-03 现代自动车株式会社 触摸输入装置以及包括该装置的车辆
US10406116B2 (en) 2015-02-06 2019-09-10 Noven Pharmaceuticals, Inc. Pressure-sensitive adhesives for transdermal drug delivery
MX371044B (es) 2015-02-06 2020-01-13 Noven Pharma Adhesivos sensibles a la presión para suministro transdérmico de fármaco.
RU2764443C2 (ru) 2016-12-20 2022-01-17 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин и полисилоксан или полиизобутилен
WO2018115001A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN110799180A (zh) 2017-06-26 2020-02-14 罗曼治疗系统股份公司 含阿塞那平和硅氧烷丙烯酸杂化聚合物的经皮治疗系统
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CN116997330A (zh) 2021-01-07 2023-11-03 诺芬药品公司 具有低水平氨基甲酸盐的透皮安非他命组合物
WO2022150431A2 (en) 2021-01-07 2022-07-14 Noven Pharmaceuticals, Inc. Amphetamine carbamate compounds and methods

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676321B2 (ja) * 1987-02-18 1994-09-28 久光製薬株式会社 クロニジン経皮投与製剤
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5719197A (en) 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5332576A (en) 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US6024974A (en) 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2223588C (en) 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US20020102291A1 (en) 1997-12-15 2002-08-01 Noven Pharmaceuticals, Inc. Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
PT1061900E (pt) 1999-01-14 2005-04-29 Noven Pharma Composicoes e metodos para libertacao de uma droga
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
EP1406633B1 (en) 2001-06-18 2011-10-05 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
EP1663179A1 (en) 2003-07-21 2006-06-07 Noven Pharmaceuticals, Inc. Composition and method for controlling drug delivery from silicone adhesive blends
WO2005025549A2 (en) 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
MEP23508A (en) 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
WO2006041907A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
WO2006041908A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
WO2006041911A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Device transdermal administration of drugs including acrylic polymers
CN101431988A (zh) 2006-02-27 2009-05-13 诺芬药品公司 包含东莨菪碱的透皮治疗系统
US7989496B2 (en) 2006-10-27 2011-08-02 Noven Pharmaceuticals, Inc. Transdermal delivery of ketoprofen polar derivatives
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
EP2506838A1 (en) 2009-12-01 2012-10-10 Noven Pharmaceuticals, INC. Transdermal testosterone device and delivery
WO2012092165A1 (en) 2010-12-29 2012-07-05 Noven Pharmaceuticals, Inc. Transdermal drug delivery system comprising levonorgestrel acetate
JP5698837B2 (ja) * 2011-04-18 2015-04-08 久光製薬株式会社 貼付剤の製造方法及び貼付剤
WO2014062494A1 (en) 2012-10-15 2014-04-24 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
AR093118A1 (es) 2012-10-25 2015-05-20 Noven Pharma Composiciones y metodos para la administracion transdermica de anfetamina
TW201431554A (zh) 2012-12-28 2014-08-16 Noven Pharma 左炔諾孕酮(levonorgestrel)及乙烯雌二醇之經皮藥物遞送系統
CA2896336C (en) 2012-12-28 2021-10-19 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents

Similar Documents

Publication Publication Date Title
JP2016504368A5 (cg-RX-API-DMAC7.html)
US9056026B2 (en) Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
JP6161668B2 (ja) ポリマーフィルム中の医薬の結晶化を防止する方法
JP2017039781A5 (cg-RX-API-DMAC7.html)
JP2010510260A5 (cg-RX-API-DMAC7.html)
CN101677969B (zh) 骨架型透皮给药系统及其制备方法
Cilurzo et al. Application of methyl methacrylate copolymers to the development of transdermal or loco-regional drug delivery systems
JP2011527697A5 (cg-RX-API-DMAC7.html)
JP5823946B2 (ja) アクリル系感圧接着剤
HK1215677A1 (zh) 经皮递送系统
CN106659702A (zh) 透皮递送体系
JP2016505006A5 (cg-RX-API-DMAC7.html)
JP2017538735A5 (cg-RX-API-DMAC7.html)
JP2016504367A5 (cg-RX-API-DMAC7.html)
EP4238580A3 (en) Transdermal delivery system including an interface mediator
JP2011500604A5 (cg-RX-API-DMAC7.html)
JP6180520B2 (ja) ロチゴチンを含有した経皮吸収製剤(Transdermalcompositioncomprisingrotigotine)
TWI710380B (zh) 抑制丙烯酸系黏著劑流動之方法及丙烯酸系黏著劑流動抑制劑
JP2011510936A5 (cg-RX-API-DMAC7.html)
JP2018524348A5 (cg-RX-API-DMAC7.html)
UA110217C2 (en) Transdermal therapeutic system with a removable protective film (release liner), inhibiting crystallization process
TWI674900B (zh) 用於經皮輸送安非他命之組合物及方法
JP2018507850A5 (cg-RX-API-DMAC7.html)